EUVIMEDEUVIMED entdecken
Crossref

Experimental Analyses of RFdiffusion Designed Miniproteins for Binding to SARS-CoV-2 Nucleocapsid Protein

Zeenat Khakerwala, Ashwani Kumar, Sujay S Gaikwad, Truptimayee Barik, Shweta Singh, Gagan Deep Gupta, Ravindra D Makde iD

Protein Engineering, Design and Selection · 2026

DOI: 10.1093/protein/gzag004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Engineering, Design and Selection, 2026. Verfasst von Zeenat Khakerwala und 6 weiteren Autor:innen. Beteiligte Einrichtung: Homi Bhabha National Institute, 2nd floor, BARC Training School Complex, Anushaktinagar, Mumbai, Maharashtra 400094, India. Hauptthemen laut MEDLINE: SARS-CoV-2, Coronavirus Nucleocapsid Proteins, Protein Engineering, Phosphoproteins. Gefördert von: Department of Atomic Energy, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Miniprotein designs are emerging as promising antibody alternatives for therapeutic and diagnostic use. Using RFdiffusion, we designed 538 binder candidates targeting both N- and C-terminal domains of the SARS-CoV-2 nucleocapsid protein, selecting 19 for recombinant production in E. coli. All were soluble and purified (8–10 mg/L yield), though 13 unexpectedly formed oligomers. CD spectroscopy confirmed proper folding and thermal refolding, with 9 miniproteins exhibiting Tm > 75°C. Binding assay revealed three miniproteins with affinities of 115 nM, 4.8 μM, and 7.32 μM. The 1.8 Å resolution crystal structure of one binder (Gpx62) matched the predicted design. However, predictive metrics (like ipTM of AlphaFold3 and computational simulations) did not align with experimental data. Together, these results reveal unintended oligomerization as a major, previously underappreciated barrier in miniprotein binder discovery, demonstrating that while RFdiffusion reliably predicts structural integrity and stability of miniprotein, its current metrics do not account for the oligomeric behavior that might critically limit binding competence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Coronavirus Nucleocapsid ProteinsProtein EngineeringPhosphoproteinsNucleocapsid ProteinsProtein BindingModels, MolecularRecombinant ProteinsEscherichia coli

Stichwörter der Autor:innen

de novo protein designN protein of SARS-CoV-2RFdiffusionSARS-CoV-2biophysical propertiesgenerative AIoligomeric miniprotein design

Substanzen

Coronavirus Nucleocapsid ProteinsRecombinant Proteinsnucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsNucleocapsid Proteins

Autor:innen und Institutionen

  • Homi Bhabha National Institute, 2nd floor, BARC Training School Complex, Anushaktinagar, Mumbai, Maharashtra 400094, India.
  • Beamline Development and Application Section, Bhabha Atomic Research Centre, Anushakti nagar, Mumbai 400085, India.
  • Protein Crystallography section, Bhabha Atomic Research Centre, Anushakti nagar, Mumbai 400085, India.

ORCID-Profile: Ravindra D Makde

Förderung

  • Department of Atomic Energy, India

Zitieren

APA

Khakerwala, Z., Kumar, A., Gaikwad, S. S., Barik, T., Singh, S., Gupta, G. D., & Makde, R. D. (2026). Experimental Analyses of RFdiffusion Designed Miniproteins for Binding to SARS-CoV-2 Nucleocapsid Protein. Protein Engineering, Design and Selection. https://doi.org/10.1093/protein/gzag004

Vancouver

Khakerwala Z, Kumar A, Gaikwad SS, Barik T, Singh S, Gupta GD, et al. Experimental Analyses of RFdiffusion Designed Miniproteins for Binding to SARS-CoV-2 Nucleocapsid Protein. Protein Engineering, Design and Selection. 2026. doi:10.1093/protein/gzag004

BibTeX
@article{Khakerwala2026,
  author = {Khakerwala, Zeenat and Kumar, Ashwani and Gaikwad, Sujay S and Barik, Truptimayee and Singh, Shweta and Gupta, Gagan Deep and Makde, Ravindra D},
  title = {Experimental Analyses of RFdiffusion Designed Miniproteins for Binding to SARS-CoV-2 Nucleocapsid Protein},
  journal = {Protein Engineering, Design and Selection},
  year = {2026},
  doi = {10.1093/protein/gzag004}
}
Kostenlos starten →